316
H.-N. Zhang et al. / Inorganica Chimica Acta 450 (2016) 315–320
pyridine dibromide (220.4 mg, 0.5 mmol), Se (94.8 mg, 1.2 mmol),
2. Experimental
K2CO3 (165.9 mg, 1.2 mmol). Yield: (245 mg 55%) (based on 2,6-bis
(isopropyllimidazolium)pyridine dibromide). Anal. Calcd. for
2.1. Materials and physical measurements
C
17H21N5Se2 (455.01): C, 44.83; H, 4.65; N, 15.39. Found: C,
44.88; H, 4.62; N, 15.36. 1H NMR (300 MHz, CDCl3): d 8.82 (d,
J = 8 Hz, pyridine, 2H), 8.04 (t, pyridine, 1H), 7.58 (d, J = 3 Hz,
imidazole, 2H), 7.02 (d, J = 3 Hz, imidazole, 2H), 5.39 (m, 2CH,
2H), 1.45 (d, J = 6 Hz, 4CH3, 12H). 13C NMR (500 MHz, CDCl3): d
155.30, 149.39, 139.72, 119.96, 119.93, 119.79, 119.7, 51.36,
22.28, 22.25 ppm. IR (KBr, cmÀ1): 3175 (w), 3132 (w), 3094 (w),
2970 (w), 2866 (w), 1666 (w), 1598 (m), 1572 (m), 1456 (s),
1416 (m), 1400 (m), 1385 (w), 1368 (w), 1337 (m), 1327 (w),
1277 (m), 1225 (s), 1153 (w), 1134 (w), 1113 (m), 1047 (w),
1018 (w), 991 (w), 883 (w), 835 (w), 804 (m), 781 (m), 718 (m),
685 (w), 664 (m), 584 (w), 554 (w), 500 (w).
Commercial reagents were analytical grade and used as received
from Aladdin and Energy chemical. All manipulations were carried
out under nitrogen using standard schlenk and vacuum-line tech-
niques. All solvents were purified and degassed by standard proce-
dures. The starting materials 2,6-bis(1-methylimidazolium)
pyridine dibromide, 2,6-bis(1-ethylimidazolium)pyridine dibro-
mide and 2,6-bis(1-isopropylimidazolium)pyridine dibromide
were synthesized according to the procedures described in the lit-
erature [55]. All catalytic reactions were monitored by TLC using
0.25 mm silica gel plates with UV indicator (60F-254). 1H and 13C
NMR were recorded on a 300 MHz or 500 MHz NMR spectrometer
at room temperature. IR spectra were recorded on a Niclolet
AVATAR-360IR spectrometer. Element analyses were performed
on an Elementar III vario EI Analyzer. Mass spectra were obtained
with MicroTof (Bruker Daltonics, Bremen, Germany) spectrometers.
2.5. Synthesis of complex [Au(Bmsp)Cl2][AuCl2] (1)
In a 25 mL Schlenk tube were placed with Bmsp (59.55 mg,
0.15 mmol), HAuCl4 (132 mg, 0.32 mmol), 5 mL methanol as sol-
vent. The mixture was stirred at room temperature overnight
and then the solvent was removed with a rotary evaporator; the
resulting solid was washed with methanol and diethyl ether, and
then dried in vacuo. The product was recrystallized from MeCN/
CH2Cl2 to give brown deep-red powder. Yield: (67.5 mg, 45%)
2.2. Synthesis of Bmsp
In a 25 mL Schlenk tube were placed with 2,6-bis(1-methylimi-
dazolium)pyridine dibromide (201.5 mg, 0.5 mmol), Se (94.8 mg,
1.2 mmol), K2CO3 (165.9 mg, 1.2 mmol) and 6.0 mL methanol as
solvent. The mixture was allowed to reflux for 12 h after which
the methanol was removed with a rotary evaporator. The remaining
solid was shaken with 3 Â 10 mL CH2Cl2 which was then filtered
and rotary evaporated. The product was recrystallized from
CH2Cl2/MeOH to give white solid. Yield: (258 mg 65%) (based on
2,6-bis(1-methylimidazolium)pyridine dibromide). Anal. Calcd.
for C13H13N5Se2 (397.20): C, 39.10; H, 3.28; N, 17.77. Found: C,
39.15; H, 3.30; N, 17.58. 1H NMR (300 MHz, CDCl3): d 8.90 (d,
J = 8 Hz, pyridine, 2H), 8.05 (t, pyridine, 1H), 7.54 (d, J = 3 Hz, imida-
zole, 2H), 6.92 (d, J = 3 Hz, imidazole, 2H), 4.52 (s, 2CH3, 6H). 13C
NMR (500 MHz, CDCl3): d 156.72, 149.40, 140.15, 120.95, 119.18,
118.97, 37.86 ppm. IR (KBr, cmÀ1): 3358 (w), 3281 (w), 3188 (w),
3165 (w), 3130 (w), 3099 (w), 1666 (w), 1624 (vs), 1571 (m),
1471 (vs), 1448 (s), 1395 (m), 1369 (m), 1290 (m), 1236 (m),
1121 (w), 1074 (w), 985 (w), 874 (w), 797 (m), 671 (w), 555 (w).
(based on Bmsp ligand). Anal. Calcd. for
C13H13Au2Cl4N5Se2
(932.94): C, 16.74; H, 1.40; N, 7.51. Found: C, 16.77; H, 1.16; N,
7.50. 1H NMR (300 MHz, CD3OD): d 8.52 (t, pyridine, 1H), 8.17 (d,
J = 2 Hz, pyridine, 2H), 7.95 (d, J = 6 Hz, imidazole, 2H), 7.70 (d,
J = 2 Hz, imidazole, 2H), 4.25 (s, 6H). 13C NMR (500 MHz, CD3OD):
d 148.06, 143.98, 138.89, 125.57, 124.02, 121.55, 38.5. ppm. ESI-MS
(positive ions) for [Au(Bmsp)]3+: m/z 595.9160 (calcd for [Au
(Bmsp)]3+ 595.9167). IR (KBr, cmÀ1): 3421(w), 2943(w), 1816(w),
1672(m), 1627(s), 1562(m), 1508(w), 1476(s), 1440(m), 1408(w),
1379(w), 1300(w), 1238(m), 1138(w), 986(w), 878(w), 802(w),
734(w), 551(w), 501(w).
2.6. Synthesis of complex [Au(Besp)Cl2][AuCl2] (2)
Prepared by the same procedure as described above for 1, using
Besp (49.65 mg, 0.15 mmol) and HAuCl4 (132 mg, 0.32 mmol).
Yield: (77.3 mg, 50%) (based on Besp ligand). Anal. Calc. for C15H17
-
2.3. Synthesis of Besp
Au2Cl4N5Se2 (961.00): C, 18.75; H, 1.78; N, 7.29. Found: C, 18.72; H,
1.71; N, 7.22. 1H NMR (300 MHz, CD3OD) d 8.51 (t, pyridine,1H),
8.20 (d, J = 2 Hz, imidazole, 2H), 8.08 (d, J = 2 Hz, imidazole,2H),
7.97 (d, J = 2 Hz, pyridine, 2H), 4.70–4.72 (m, 4H, CH2), 1.60
(t, 2CH3, 6H). 13C NMR (500 MHz, CD3OD) d 148.08, 146.59,
143.99, 124.64, 123.90, 122.09, 47.19, 13.95. ESI-MS (positive ions)
for [Au(Besp)]3+: m/z 623.9461 (calcd for [Au(Besp)]3+ 623.9480).
IR (KBr, cmÀ1): 3395 (w), 3138 (w), 3070 (w), 2976 (w), 2929
(w), 2868 (w), 1732 (w), 1627 (w), 1597 (w), 1554 (w), 1458 (s),
1431 (m), 1398 (w), 1352 (w), 1301 (w), 1267 (m), 1221 (m),
1134 (w), 1088 (w), 1043 (w), 995 (w), 954 (w), 814 (w), 775
(w), 735 (w), 679 (w), 544 (w), 501 (w).
The synthesis procedure was similar to the ligand Bmsp to
afford the white solid Besp, using 2,6-bis(1-ethylimidazolium)pyr-
idine dibromide (217 mg, 0.5 mmol), Se (94.8 mg, 1.2 mmol),
K2CO3 (165.9 mg, 1.2 mmol). Yield: (213 mg 50%) (based on 2,6-
bis(1-ethylimidazolium)pyridine dibromide). Anal. Calcd. for
C15H17N5Se2 (426.98): C, 42.16; H, 4.01; N, 16.40. Found: C,
42.20; H, 4.05; N, 16.36. 1H NMR (300 MHz, CDCl3): d 8.86 (d,
J = 8 Hz, pyridine, 2H), 8.12 (t, pyridine, 1H), 7.57 (d, J = 3 Hz,
imidazole, 2H), 6.98 (d, J = 3 Hz, imidazole, 2H), 4.26 (m, 2CH2
4H), 1.46 (t, 2CH3, 6H). 13C NMR (500 MHz, CDCl3): d 155.73,
149.39, 139.91, 119.60, 119.35, 119.15, 45.34, 14.60 ppm. IR (KBr,
cmÀ1): 3177 (w), 3140 (w), 3097 (w), 2965 (w), 2864 (w), 1647
(w), 1605 (s), 1576 (m), 1533 (w), 1464 (s), 1408 (s), 1392 (s),
1354 (w), 1303 (m), 1281 (s), 1258 (s), 1223 (s), 1155 (m), 1134
(m), 1115 (m), 1076 (w), 1040 (w), 995 (w), 985 (w), 966 (w),
949 (m), 903 (w), 802 (s), 800 (s), 785 (m), 773 (m), 735 (w),716
(m), 688 (w), 655 (m), 599 (w), 509 (w).
2.7. Synthesis of complex [Au(Bpsp)Cl2][AuCl2]À (3)
Prepared by the same procedure as described above for 1, using
Bpsp (68.0 mg, 0.15 mmol) and HAuCl4 (132 mg, 0.32 mmol).
Yield: (87.3 mg, 55%) (based on Bpsp ligand). Anal. Calc. for C17H21
-
Au2Cl4N5Se2 (989.05): C, 20.64; H, 2.14; N, 7.08. Found: C, 20.70; H,
2.18; N, 7.15. 1H NMR (300 MHz, CD3OD) d 8.53 (t, pyridine, 1H),
8.25 (d, J = 2 Hz, imidazole, 2H), 8.12 (d, J = 2 Hz, imidazole, 2H),
7.99 (d, pyridine, 2H), 5.48 (m, CH, 2H), 1.57 (d, CH3, 6H), 1.28
(d, CH3, 6H). 13C NMR (500 MHz, CD3OD) d 148.08, 144.47,
137.10, 124.93, 121.99, 121.42, 54.40, 21.64, 21.00. ESI-MS
2.4. Synthesis of Bpsp
The synthesis procedure was similar to the ligand Bmsp to
afford the white solid Bpsp, using 2,6-bis(isopropyllimidazolium)